Dermira Company Profile (NASDAQ:DERM)

About Dermira

Dermira logoDermira, Inc. is a biopharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated therapies for dermatologic diseases. The Company's portfolio includes three late-stage product candidates that target unmet needs and market opportunities, such as Cimzia (certolizumab pegol), DRM04 and DRM01. Cimzia is an injectable biologic tumor necrosis factor-alpha inhibitor, or TNF inhibitor, that is approved and marketed for the treatment of numerous inflammatory diseases spanning multiple medical specialties, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. DRM04 is a topical, small-molecule anticholinergic product for the treatment of hyperhidrosis. DRM01 is a topical, small-molecule sebum inhibitor for the treatment of acne.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: DERM
  • CUSIP:
Key Metrics:
  • Previous Close: $31.51
  • 50 Day Moving Average: $31.77
  • 200 Day Moving Average: $27.34
  • 52-Week Range: $17.42 - $35.75
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.70
  • P/E Growth: 0.00
  • Market Cap: $1.11B
  • Outstanding Shares: 35,379,000
  • Beta: 0.84
Additional Links:
Companies Related to Dermira:

Analyst Ratings

Consensus Ratings for Dermira (NASDAQ:DERM) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $44.75 (42.88% upside)

Analysts' Ratings History for Dermira (NASDAQ:DERM)
DateFirmActionRatingPrice TargetDetails
6/22/2016Needham & Company LLCReiterated RatingBuy$46.00View Rating Details
6/2/2016Leerink SwannReiterated RatingBuy$46.00 -> $47.00View Rating Details
6/2/2016WedbushBoost Price TargetOutperform$42.00 -> $46.00View Rating Details
3/16/2016Citigroup Inc.Lower Price TargetBuy$42.00 -> $40.00View Rating Details
8/19/2015Cowen and CompanyInitiated CoverageOutperform$40.00View Rating Details
8/7/2015GuggenheimBoost Price TargetBuy$22.00 -> $40.00View Rating Details
(Data available from 8/30/2014 forward)


Earnings History for Dermira (NASDAQ:DERM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q2($0.86)($0.89)ViewN/AView Earnings Details
5/10/2016Q1($0.94)($0.95)ViewListenView Earnings Details
3/3/2016Q4($0.95)($1.04)ViewListenView Earnings Details
11/10/2015Q3($0.77)($0.58)ViewN/AView Earnings Details
8/13/2015Q2($0.81)($0.69)ViewN/AView Earnings Details
5/12/2015Q1($0.65)($0.57)ViewN/AView Earnings Details
3/25/2015Q4($0.59)($0.29)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Dermira (NASDAQ:DERM)
Current Year EPS Consensus Estimate: $-3.52 EPS
Next Year EPS Consensus Estimate: $-3.23 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($1.00)($1.00)($1.00)
Q2 20161($0.96)($0.96)($0.96)
Q3 20161($0.64)($0.64)($0.64)
Q4 20161($0.94)($0.94)($0.94)
(Data provided by Zacks Investment Research)


Dividend History for Dermira (NASDAQ:DERM)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Dermira (NASDAQ:DERM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Christopher M GriffithVPSell1,303$31.75$41,370.25View SEC Filing  
8/11/2016Andrew GuggenhimeCFOSell10,000$31.02$310,200.00View SEC Filing  
8/1/2016Eugene A BauerInsiderSell2,500$33.18$82,950.00View SEC Filing  
8/1/2016Thomas G WiggansCEOSell11,000$33.19$365,090.00View SEC Filing  
8/1/2016William R RingoDirectorSell500$33.65$16,825.00View SEC Filing  
7/15/2016Christopher M GriffithVPSell1,303$30.02$39,116.06View SEC Filing  
7/11/2016Andrew GuggenhimeCFOSell10,000$30.15$301,500.00View SEC Filing  
7/5/2016Thomas G WiggansCEOSell11,000$29.62$325,820.00View SEC Filing  
7/1/2016Eugene A BauerInsiderSell2,500$29.48$73,700.00View SEC Filing  
6/23/2016Luis C PenaInsiderSell10,000$30.01$300,100.00View SEC Filing  
6/15/2016Luis C PenaInsiderSell10,000$29.47$294,700.00View SEC Filing  
6/13/2016Christopher M GriffithVPSell4,405$30.16$132,854.80View SEC Filing  
6/1/2016Eugene A BauerInsiderSell2,500$31.65$79,125.00View SEC Filing  
6/1/2016Thomas G WiggansCEOSell11,000$31.57$347,270.00View SEC Filing  
5/2/2016Eugene A BauerInsiderSell2,500$25.09$62,725.00View SEC Filing  
5/2/2016Thomas G WiggansCEOSell9,000$25.11$225,990.00View SEC Filing  
4/1/2016Eugene A BauerInsiderSell2,500$20.84$52,100.00View SEC Filing  
4/1/2016Thomas G WiggansCEOSell7,000$20.69$144,830.00View SEC Filing  
3/1/2016Eugene A BauerInsiderSell2,500$22.55$56,375.00View SEC Filing  
3/1/2016Thomas G WiggansCEOSell7,000$22.57$157,990.00View SEC Filing  
2/1/2016Eugene A BauerInsiderSell2,500$27.26$68,150.00View SEC Filing  
2/1/2016Thomas G WiggansCEOSell9,000$27.25$245,250.00View SEC Filing  
1/4/2016Eugene A BauerInsiderSell2,500$33.17$82,925.00View SEC Filing  
1/4/2016Thomas G WiggansCEOSell11,000$33.17$364,870.00View SEC Filing  
12/1/2015Eugene A BauerInsiderSell2,500$29.65$74,125.00View SEC Filing  
11/2/2015Eugene A BauerInsiderSell2,500$27.82$69,550.00View SEC Filing  
10/1/2015Eugene A BauerInsiderSell2,500$22.87$57,175.00View SEC Filing  
9/14/2015Eugene A BauerInsiderSell22,500$28.05$631,125.00View SEC Filing  
11/25/2014Matthew K FustDirectorBuy6,000$16.77$100,620.00View SEC Filing  
10/8/2014Bay City Capital LlcDirectorBuy69,112$16.00$1,105,792.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Dermira (NASDAQ:DERM)
DateHeadline logoWill Dermira, Inc. (NASDAQ:DERM) Surprise This Quarter? - Investor Newswire (NASDAQ:DERM) - August 28 at 4:17 PM logoDermira, Inc. (NASDAQ:DERM) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:DERM) - August 25 at 4:38 PM logoWill Dermira, Inc. (NASDAQ:DERM) Hit $47 Price Target? - Investor Newswire (NASDAQ:DERM) - August 18 at 8:48 AM logoDERMIRA, INC. Financials (NASDAQ:DERM) - August 17 at 4:46 PM logoCommit To Buy Dermira At $30, Earn 22.9% Annualized Using Options (NASDAQ:DERM) - August 16 at 4:41 PM logoDermira, Inc. (DERM) Ownership Up in Latest Report from Timessquare Capital Management, LLC - Finance Daily (NASDAQ:DERM) - August 11 at 4:43 PM logoBRIEF-Dermira reports Q2 loss per share $0.89 (NASDAQ:DERM) - August 9 at 8:58 AM logoDermira Inc.: Dermira Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:DERM) - August 9 at 8:58 AM logoDermira reports 2Q loss (NASDAQ:DERM) - August 9 at 8:58 AM logoDermira Inc.: Dermira Reports Second Quarter 2016 Financial Results and Provides Corporate Update - The Wall Street Transcript (NASDAQ:DERM) - August 8 at 9:57 PM logoDERMIRA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:DERM) - August 8 at 4:42 PM logoDERMIRA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:DERM) - August 8 at 4:42 PM logoDermira Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:DERM) - August 8 at 4:42 PM logoJennison Associates LLC Significantly Raises Its Position in Dermira, Inc. (DERM) Last Quarter - Finance Daily (NASDAQ:DERM) - August 3 at 4:42 PM logoStocks within Analysts Spotlight: Dermira, Inc. (NASDAQ:DERM) , Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) - Street Updates (NASDAQ:DERM) - August 1 at 9:29 AM logoSacramento medical equipment company raises second VC round this year (NASDAQ:DERM) - July 29 at 4:40 PM logoDermira, Inc. (NASDAQ:DERM) Updated Price Targets - FTSE News (NASDAQ:DERM) - July 29 at 11:36 AM logoGlobal Systemic Psoriasis Therapeutics Market to Grow at a CAGR of 9.41% During the Period 2016 - 2020; Finds New Report (NASDAQ:DERM) - July 28 at 10:30 AM logoCan Shares Of Dermira, Inc. (NASDAQ:DERM) Hit $47? - Investor Newswire (NASDAQ:DERM) - July 27 at 10:15 PM logoIs $47 Price Target Attainable For Dermira, Inc. (NASDAQ:DERM)? - Investor Newswire (NASDAQ:DERM) - July 21 at 8:03 AM
News IconStock in Positive Territory for the Quarter: Dermira, Inc. (NASDAQ:DERM) - Engelwood Daily (NASDAQ:DERM) - July 19 at 4:40 PM
News IconShares Experiencing a Downtrend: Dermira, Inc. (NASDAQ:DERM) - TGP (NASDAQ:DERM) - July 16 at 5:01 AM logoDermira, Inc. breached its 50 day moving average in a Bullish Manner : DERM-US : July 15, 2016 (NASDAQ:DERM) - July 15 at 8:08 AM
News IconAfter Today's Huge Decline, Is Dermira Inc's Near-Term Analysis Negative? - Consumer Eagle (NASDAQ:DERM) - July 13 at 9:53 PM logoStrong Sell Calls For Dermira, Inc. (NASDAQ:DERM) At 0 - Investor Newswire (NASDAQ:DERM) - July 13 at 9:53 PM
News IconDermira (NASDAQ:DERM) Sentiment Change Report - Press Telegraph (NASDAQ:DERM) - July 13 at 4:43 PM
News IconWere Analysts Bearish Dermira Inc (NASDAQ:DERM) This Week? - Press Telegraph (NASDAQ:DERM) - July 13 at 4:43 PM
News IconStock Performance Rundown on: Dermira, Inc. (NASDAQ:DERM) - Press Telegraph (NASDAQ:DERM) - July 13 at 4:43 PM logoBroker Outlook For Dermira, Inc. (NASDAQ:DERM) - Fiscal Standard (NASDAQ:DERM) - July 13 at 4:43 PM logoOption Market: Dermira Inc. Risk Hits An Elevated Level - CML News (NASDAQ:DERM) - July 7 at 9:47 PM logoInsider Trading Activity - Dermira, Inc. (NASDAQ:DERM) - Finance Daily (NASDAQ:DERM) - July 6 at 10:25 PM logoDermira, Inc. (NASDAQ:DERM) Expected to Reach Highs Of $47 - Investor Newswire (NASDAQ:DERM) - July 6 at 10:25 PM
News IconShare Performance Recap for: Dermira, Inc. (NASDAQ:DERM) - Press Telegraph (NASDAQ:DERM) - July 5 at 4:32 PM logoThis Weeks Broker Price Targets For Dermira, Inc. (NASDAQ:DERM) - Fiscal Standard (NASDAQ:DERM) - July 5 at 9:21 AM
News IconDermira Inc Can't Burn Your Short Portfolio. Has Another Weak Session - Press Telegraph (NASDAQ:DERM) - June 30 at 9:57 PM logoStrong Sell Calls Recommendations For Dermira, Inc. (NASDAQ:DERM) At 0 - Investor Newswire (NASDAQ:DERM) - June 29 at 9:36 PM logoWhy Need to Watch: Dermira, Inc. (NASDAQ:DERM), Bristol-Myers Squibb Company (NYSE:BMY), Rite Aid ... - KC Register (NASDAQ:DERM) - June 29 at 4:34 PM logoDermira, Inc. breached its 50 day moving average in a Bearish Manner : DERM-US : June 28, 2016 (NASDAQ:DERM) - June 28 at 8:33 AM logoNext Weeks Broker Price Targets For Dermira, Inc. (NASDAQ:DERM) - Fiscal Standard (NASDAQ:DERM) - June 27 at 4:34 PM
News IconHow Many Dermira Inc (NASDAQ:DERM)'s Analysts Are Bearish? - Press Telegraph (NASDAQ:DERM) - June 27 at 4:34 PM logoForm 4 Dermira, Inc. For: Jun 21 Filed by: CRAVES FRED B - (NASDAQ:DERM) - June 24 at 11:19 AM logoLooking At Post-Earnings Stock Movement: Dermira, Inc. (NASDAQ:DERM) - iStreetWire (NASDAQ:DERM) - June 23 at 3:30 PM logoStrong Buy Calls Count For Dermira, Inc. (NASDAQ:DERM) At 2 - Investor Newswire (NASDAQ:DERM) - June 23 at 3:30 PM logoDERMIRA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:DERM) - June 22 at 9:49 PM logoDermira, Inc. (NASDAQ:DERM) Current Analyst Ratings - Fiscal Standard (NASDAQ:DERM) - June 22 at 4:45 PM logoDERMIRA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:DERM) - June 22 at 4:10 PM logoDermira, Inc. (NASDAQ:DERM) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:DERM) - June 20 at 4:30 PM logoTrend Of Rating Given To Dermira, Inc. (NASDAQ:DERM) - Investor Newswire (NASDAQ:DERM) - June 16 at 8:56 AM logoDermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares (NASDAQ:DERM) - June 13 at 4:05 PM
News IconTrending Stock Analysis: Dermira, Inc. (NASDAQ:DERM) - News Oracle (NASDAQ:DERM) - June 9 at 11:52 AM


Dermira (NASDAQ:DERM) Chart for Tuesday, August, 30, 2016

Last Updated on 8/30/2016 by Staff